Search filters

List of works by John Wikstrand

A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics

scientific article

An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial

scientific article published on January 2010

Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials

scientific article published on 10 October 2017

Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure).

scientific article published on October 2010

Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction

scientific article

Declining Risk of Sudden Death in Heart Failure

scientific article

Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF.

scientific article published on 14 February 2015

Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure).

scientific article published on 30 April 2014

Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis

scientific article

Fatigue as a Predictor of Outcome in Patients With Heart Failure

article

Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

scientific article published on April 17, 2012

Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure

scientific article published on 01 December 2019

Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA.

scientific article published on 3 December 2013

Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA).

scientific article published on 25 May 2010

International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction

scientific article published on 18 November 2014

Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure

scientific article published on April 2017

Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.

scientific article published on 23 December 2015

Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA).

scientific article published on 21 June 2016

Novel extracellular matrix biomarkers as predictors of adverse outcome in chronic heart failure: association between biglycan and response to statin therapy in the CORONA trial

scientific article published on 7 November 2014

Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.

scientific article published on 07 January 2011

Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials

scientific article published on 27 June 2012

Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in

scientific article

Predictive value of endostatin in chronic heart failure patients with poor kidney function

scientific article published on 22 November 2014

Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide

scientific article published on 24 January 2009

Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial

scientific article

Prognostic value of CXCL16 in patients with left ventricular systolic dysfunction and heart failure

scientific article published on 26 May 2013

Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

scientific article published on 28 September 2014

Response to Letter Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della So

scientific article published in December 2015

Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca

scientific article published on 25 March 2015

Rosuvastatin in older patients with systolic heart failure

scientific article

Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology

scientific article published on 2 February 2012

Telomere length and outcomes in ischaemic heart failure: data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA).

scientific article

The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

scientific article published on 29 October 2012

Thyroid-stimulating hormone and clinical outcomes: the CORONA trial (controlled rosuvastatin multinational study in heart failure).

scientific article published on 25 January 2014